Biden to pick FTC member Chopra to head consumer financial regulator

Reuters | Washington DC | Updated: 18-01-2021 06:47 IST | Created: 18-01-2021 06:47 IST
Biden to pick FTC member Chopra to head consumer financial regulator

U.S. President-elect Joe Biden will nominate Federal Trade Commission member Rohit Chopra to head the Consumer Financial Protection Bureau, Politico reported on Sunday, citing unnamed sources familiar with the decision.

Chopra, an ally of Democratic Senator Elizabeth Warren, had been considered a top candidate for the job running the agency, which had been weakened by the administration of outgoing President Donald Trump.

A spokesperson for Biden's transition team could not be immediately reached for comment.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)



Addressing conflict-related sexual violence at long last

... ...

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...


Latest News

Riskcovry raises USD 5 mn from Omidyar Network India, others

InsurTech startup Riskcovry Tuesday raised USD 5 million around Rs 36 crore in Series A funding round led by Omidyar Network India ONI Its existing investors - Bharat Inclusion Seed Fund, Varanium Capital and Better Capital also participate...

Death toll from explosions in Equatorial Guinea rises to 98

The death toll from a series of explosions at a military barracks in Equatorial Guinea rose by dozens to at least 98 killed after more bodies were recovered, the government said Tuesday. The blasts on Sunday in the Mondong Nkuantoma neighbo...

Dr. Narayan Hulse's Book on Joint Replacement Unveiled by Shri Tejasvi Surya

The book aims to address various concerns pertaining to joint replacements Bengaluru, Karnataka, India NewsVoir A book authored by Dr. Narayan Hulse- Director - Department of Orthopedics Joint Replacement at Fortis Hospital, Bannerghatta R...

Intranasal COVID vaccine candidate in early clinical stage of development in India: Govt

An intranasal vaccine candidate BBV154, being developed by Bharat Biotech, is in early clinical stage of development in India, Minister of State for Health Ashwini Choubey told the Rajya Sabha on Tuesday.Choubey was responding to a question...

Give Feedback